| Literature DB >> 32401847 |
Isabela Bispo Santos da Silva Costa1,2, Cristina Salvadori Bittar1,2, Stephanie Itala Rizk1,2, Antônio Everaldo de Araújo Filho1, Karen Alcântara Queiroz Santos1, Theuran Inahja Vicente Machado1, Fernanda Thereza de Almeida Andrade1, Thalita Barbosa González1, Andrea Nataly Galarza Arévalo1, Juliano Pinheiro de Almeida1, Fernando Bacal2, Gláucia Maria Moraes de Oliveira3, Marcus Vinícius Guimarães de Lacerda4, Silvio Henrique Barberato5,6, Antonio Carlos Palandri Chagas2,7, Carlos Eduardo Rochitte2,8, José Antonio Franchini Ramires2, Roberto Kalil Filho2, Ludhmila Abrahão Hajjar1,2.
Abstract
In face of the pandemic of the novel coronavirus disease 2019 (COVID-19), the management of patients with cardiovascular risk factors and/or disease is challenging. The cardiovascular complications evidenced in patients with COVID-19 derive from several mechanisms, ranging from direct viral injury to complications secondary to the inflammatory and thrombotic responses to the infection. The proper care of patients with COVID-19 requires special attention to the cardiovascular system aimed at better outcomes.Entities:
Mesh:
Year: 2020 PMID: 32401847 DOI: 10.36660/abc.20200279
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000